Mibe Arzneimittel

mibe GmbH Arzneimittel is a prominent German pharmaceutical manufacturer and the primary production hub for the Dermapharm Group. Based in Sandersdorf-Brehna, the company operates a state-of-the-art facility specializing in the development and manufacture of a diverse portfolio of prescription and over-the-counter (OTC) medicines, including generics, vitamins, and specialized therapies. mibe produces approximately 90% of Dermapharm's product range and provides critical contract manufacturing services, most notably for the COVID-19 vaccine on behalf of BioNTech. Its expertise spans multiple dosage forms, including sterile ampoules, freeze-dried products, tablets, and topical treatments. The company focuses on therapeutic areas such as gynecology, dermatology, cardiovascular health, and bone metabolism, maintaining a strong commitment to "Made in Germany" quality standards.